The DOI matches its Crossref record; 922 of the 930 references it cites were found in a registry or an index.
Clinical Pharmacology of Systemic Antifungal Agents: A Comprehensive Review of Agents in Clinical Use, Current Investigational Compounds, and Putative Targets for Antifungal Drug Development
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Due to this toxicity, the use of amphotericin B in high concentrations may be harmful and cause damage to human tissues, such as the kidneys [26].”
From Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens (2018) · cites this paper as [26]
Citations
Cites
Principles and Practice of Infectious Diseases.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-818_5 · Cited by 12,045
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Regulation of the mevalonate pathway
Goldstein, J. L., & Brown, M. S. (1990) · Nature · doi:10.1038/343425a0 · Cited by 5,394
ABC Transporters: From Microorganisms to Man
Higgins, C. F. (1992) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.08.110192.000435 · Cited by 3,985
Tabor, C. W., & Tabor, H. (1984) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.53.070184.003533 · Cited by 3,111
DNA TOPOISOMERASE POISONS AS ANTITUMOR DRUGS
Liu, L. F. (1989) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.58.070189.002031 · Cited by 1,805
Cell Wall Chemistry, Morphogenesis, and Taxonomy of Fungi
Bartnicki-García, S. (1968) · Annual Review of Microbiology · doi:10.1146/annurev.mi.22.100168.000511 · Cited by 1,569
Goodman, J. L., Winston, D. J., Greenfield, R. A., Chandrasekar, P. H., Fox, B. C., Kaizer, H., Shadduck, R. K., Shea, T. C., Stiff, P. J., Friedman, D. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203263261301 · Cited by 1,164
Secular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990
Beck‐Sagué, C. M., Jarvis, W. R., & System, N. N. I. S. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.5.1247 · Cited by 1,140
Hancock, R. E. W. (1997) · The Lancet · doi:10.1016/s0140-6736(97)80051-7 · Cited by 1,098
Research works printed but not linked: 18
- Atkinson, 1969, Pharmacokinetics of intrathecal administered amphotericin B., Am. Rev. Respir. Dis., 99, 917
- Benhamu, 1991, Does ketoconazole prevent fungal infection in children treated with high-dose chemotherapy and bone-marrow transplantation?, Bone Marrow Transplant., 7, 127
- Bernardo, 1994, The effect of L-arginine on amphotericin B-induced nephrotoxicity., J. Am. Soc. Nephrol., 5, 917
- Brammer, 1987, A review of the pharmacokinetics of fluconazole (UK-49,858) in laboratory animals and man, 141
- Feldman, 1992, The use of granulocyte-stimulating factor (GCSF) enhanced granulocyte transfusions from normal donors in patients with neutropenia related fungal infections, Blood, 80, 414a
- G. Gaenger, G. Just-Nuebling, M. Eichel, R. Hoika, W. Stille (1993). Itraconazole solution in patients with non-response to fluconazole. In Abstracts of the IXth International Conference on AIDS, abstract 1394.
- Gascoigne, 1981, The kinetics of ketoconazole in animals and man., Clin. Res. Rev., 1, 177
- Gelfand, 1988, Amphotericin B treatment of human mononuclear cells in vitro results in secretion of tumor necrosis factor and interleukin-1., Clin. Res., 36, 456
- Graybill, 1982, Ketoconazole therapy for systemic fungal infections: Inadequacy of standard dose regimens., Am. Rev. Respir. Dis., 126, 171
- Gupta, 1994, Antifungal agents: An overview. Part II., J. Am. Acad. Dermatol., 30, 911, 10.1016/S0190-9622(94)70112-1 · DOI
- Hiemenz, 1995, Emergency use of amphotericin B lipid complex (ABLC) in the treatment of patients with aspergillosis historical control comparison with amphotericin B, Blood, 86, 849a
- Jolidon, 1993, 2,3 oxidosqualene-lanosterol cyclase, an attractive target for antifungal drug design.
- Moore, 1995, Hematopoietic reconstitution: New approaches., Clin. Cancer Res., 1, 3
- Peeters, 1986, Itraconzole, a new orally active triazole derivative for treatment of vaginal candidosis., Curr. Ther. Res., 39, 496
- Plempel, 1988, Antimycotic effects of BAY R 3783 in vitro and on dermatophytoses and opportunistic mycoses of the organs in vivo, Rev. lb. Micol., 5, 0
- Ringden, 1993, Clinical experience with AmBisome with special emphasis on experience with children., Bone Marrow Transplant., 12, S149
- Schaude, 1988, Biological activity of SDZ 89485 in animal models., Rev. lb. Micol., 5, P51
- Shepard, 1986, Cyclosporin-ketoconazole: A potentially dangerous drug interaction., Clin. Pharmacol., 6, 468
Cited by
Sorted by citations
Items 301–377 of 377
Non-Aspergillus Fungal Infections in Transplant Patients
Revankar, S. G. (2021) · Springer eBooks · doi:10.1007/978-3-030-25869-6_46 · Cited by 2
Innovations in Treating Sporotrichosis: Drug Repurposing and Lead Compound Synthesis
de Carvalho, A. S., de Freitas, G. R. M., Nicoletti, C. D., da Silva, F. D. C., Futuro, D. O., Ferreira, V. F., & Ferreira, P. G. (2024) · Current Organic Chemistry · doi:10.2174/0113852728283383240111055602 · Cited by 2
Recent Developments in Epidemiology and Management of Invasive Fungal Infections
Groll, A. H., & Walsh, T. J. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-333-0_14 · Cited by 2
Review of Amphotericin B for Invasive Fungal Infections in Neonates and Children
(2020) · Pediatric Infectious Disease · doi:10.5005/jp-journals-10081-1240 · Cited by 3
Lewis, R. E. (2014) · ASM Press eBooks · doi:10.1128/9781555815523.ch33 · Cited by 2
Coloma, P. M., Schuemie, M. J., Trifirò, G., Furlong, L. I., van Mulligen, E. M., Bauer‐Mehren, A., Avillach, P., Kors, J. A., Sanz, F., Mestres, J., et al. (2013) · PLoS ONE · doi:10.1371/annotation/8824e161-bf8f-4f78-81e0-a62a1540276d · Cited by 2
Host Immune Responses to Pathogenic Fungi and Contemporary Therapeutic Strategies
Shallal, A. F., Razaq, C. H., Ahmed, A. S., Ahmed, S. S., Eyüpoğlu, V., & Salman, R. S. (2026) · Journal of Mycology and Truffle · doi:10.65999/mycotruffle.2026.26 · Cited by 1
Schmitt, H., Krawinkel, M. B., & Kobbe, R. (2014) · Springer eBooks · doi:10.1007/978-3-642-41866-2_102 · Cited by 1
Antifungal Therapy in The ICU: The Bug, the Drug, and the Mug
Pereira, J. M., & Paiva, J. A. (2011) · Annual update in intensive care and emergency medicine · doi:10.1007/978-3-642-18081-1_47 · Cited by 1
Candidacidal Action of CF66I, an Antifungal Compound Produced by Burkholderia Cepacia
Li, X., Yu, H., & Quan, C.-S. (2011) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v10i5.6 · Cited by 1
New therapeutic options for invasive fungal diseases
Rodriguez, C. A., & Patrick, C. C. (2001) · Seminars in Pediatric Infectious Diseases · doi:10.1053/spid.2001.26638 · Cited by 1
Kumar, A., Agrawal, A., Chauhan, D., & Saini, P. (2020) · Anti-Infective Agents · doi:10.2174/2211352518999201022191232 · Cited by 1
Groll, A. H., & Walsh, T. J. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4044-6.50257-0 · Cited by 1
CHU, J. H., Antachopoulos, C., & Walsh, T. J. (2008) · Elsevier eBooks · doi:10.1016/b978-0-323-02041-1.50011-0 · Cited by 1
de Almeida, P. S. V. B., Maia, J. R. D. S., de Souza, M. C., & Pacheco, A. G. (2022) · The Journal of Engineering and Exact Sciences · doi:10.18540/jcecvl8iss7pp14608-01i · Cited by 1
Singha, J., & Saikia, J. P. (2024) · Natural Product Research · doi:10.1080/14786419.2024.2360689 · Cited by 1
Promjan, S., Chan, L. W., Heng, P. W. S., & Boonme, P. (2024) · Pharmaceutical Sciences Asia · doi:10.29090/psa.2024.02.24.1498 · Cited by 1
Invasive fungal infections in children: advances and perspectives
Groll, A. H., Köhler, J. R., & Walsh, T. J. (2007) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8099-1_16 · Cited by 1
Pneumonia in patients after hematopoietic stem cell transplantation
Styczyński, J. (2017) · Oncoreview · doi:10.24292/01.or.090817 · Cited by 1
Cottom, L., & McPhee, A. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00133-x · Cited by 1
Lewis, R. E., & Fothergill, A. W. (2015) · Springer eBooks · doi:10.1007/978-3-319-13090-3_7 · Cited by 1
Chapter 17. Progress in antifungal drug discovery
Anderson, M. B., Roemer, T., & Fabrey, R. (2003) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(03)38018-2 · Cited by 1
Pharmacokinetics of voriconazole in horses and alpacas
Chan, H. M. (2008) · Cited by 1
Caspofungin in Pediatric Patients
Lehrnbecher, T., & Groll, A. H. (2008) · Pediatric Health · doi:10.2217/17455111.2.6.677 · Cited by 1
Systemic Candida Infection in the ICU
Svoboda, P., & Kantorová, I. (2006) · Yearbook of intensive care and emergency medicine · doi:10.1007/3-540-33396-7_55 · Cited by 1
Groll, A. H., Kolve, H., & Walsh, T. J. (2005) · Side effects of drugs annual · doi:10.1016/s0378-6080(05)80449-0 · Cited by 1
Fungal Drug Resistance and Pharmacologic Considerations of Dosing Newer Antifungal Therapies
Lewis, R. E., & Perlin, D. S. (2011) · Humana Press eBooks · doi:10.1007/978-1-60761-644-3_28
Culbreath, M. (2006) · Digital Commons - University of South Florida (University of South Florida)
Pharmacokinetic considerations for the use of newer antifungal agents
Lewis, R. E. (2008) · Current Fungal Infection Reports · doi:10.1007/s12281-008-0002-6
Systemic Candida Infection in the ICU
Svoboda, P., & Kantorová, I. (2007) · Springer eBooks · doi:10.1007/0-387-35096-9_55
Medical Management of Fungal Sinusitis
Thiagarajan, B., & Ramamoorthy, G. (2013)
Update on antifungal treatment in neutropenic patients
Hung, I. F. (2008) · The HKU Scholars Hub (University of Hong Kong)
Jeyam, M., Arangaraj, M., Ravikumar, P., & Shalini, G. (2014) · Cited by 1
Mykosen bei Kindern und Jugendlichen
Schmitt, H. J. (2015) · Springer eBooks · doi:10.1007/978-3-642-54671-6_125-1
Patankar, N. A. (2010) · cIRcle (University of British Columbia) · doi:10.14288/1.0092744
Antifungal Pharmacology: A Review.
Bs, B., Sagar, P., Puranik, S., Sreenivasa, S., & Rao, M. C. (2014) · Research and reviews : journal of pharmaceutics and nanotechnology
Kobbe, R. (2014)
Molekulare Analyse der Darmflora von Patienten mit hämatologischen Krebserkrankungen
Goldenberg, O. (2007) · DepositOnce · doi:10.14279/depositonce-1605
Medical management of invasive fungal sinusitis
(2007) · The Internet Journal of Otorhinolaryngology · doi:10.5580/1303
Aspergillosis and its resistance: Marine natural products as future treatment
Saurav, K., Saha, S., Singh, M. P., Sarkar, S., Dharumadurai, D., & Каннабиран, К. (2015) · CRC Press eBooks · doi:10.1201/b19224-16
Clinically Promising New Triazoles for Systemic Fungal Infections
Neely, M. N., Sheehan, D. J., & Ghannoum, M. A. (2004) · Springer eBooks · doi:10.1007/978-3-662-10380-7_16
Disseminated Blastomycosis Presenting as Obstructive Renal Mass Treated With Fluconazole
Yetmar, Z. A., Cevallos, E. C., Pritt, B. S., & DeSimone, D. C. (2020) · The American Journal of Medicine · doi:10.1016/j.amjmed.2019.12.004
Non-Aspergillus Fungal Infections in Transplant Patients
Revankar, S. G. (2020) · Springer eBooks · doi:10.1007/978-3-030-01751-4_46-1
Dolle, R. E., Mydock-McGrane, L. K., Janetka, J. W., Hammill, J. T., Guy, R. K., Debnath, A., Cheuka, P. M., Manach, C. L., Chibale, K., Elhammer, Å. P., et al. (2021) · Burger's Medicinal Chemistry and Drug Discovery · doi:10.1002/0471266949.bmc288
Schmitt, H. J. (2007) · Springer eBooks · doi:10.1007/978-3-540-76460-1_101
Groll, A. H., & Walsh, T. J. (2014) · ASM Press eBooks · doi:10.1128/9781555815523.ch30
Richardson, M. D. (2010) · doi:10.1002/9780470688618.taw0161
Combating human fungal infections
Mir, M. A., Qadri, H., Aisha, S., & Shah, A. H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-96127-1.00010-3
Antifungal azoles [for systemic use]
(2015) · Elsevier eBooks · doi:10.1016/b978-0-444-53717-1.00313-9
Jamal, J., & Roberts, J. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-44034-7_10
Pomeroy, C., & Goodman, N. L. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-036-0_6
(2015) · Elsevier eBooks · doi:10.1016/b978-0-444-53717-1.00286-9
(2006) · Elsevier eBooks · doi:10.1016/b0-44-451005-2/00514-3
Schmitt, H. J. (2003) · Springer eBooks · doi:10.1007/978-3-662-09176-0_100
Groll, A. H., & Walsh, T. J. (2002) · Side effects of drugs annual · doi:10.1016/s0378-6080(02)80034-4
Procop, G. W., Hayden, R. T., & Roberts, G. D. (2008) · Wiley eBooks · doi:10.1128/9781555815455.ch10
(2006) · Elsevier eBooks · doi:10.1016/b0-44-451005-2/00521-0
Irwin, R. G., Groll, A. H., & Walsh, T. J. (1999) · Side effects of drugs annual · doi:10.1016/s0378-6080(99)80032-4
(2010) · Elsevier eBooks · doi:10.1016/b978-0-444-53272-5.50007-8
Wiederhold, N. P., & Patterson, T. F. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781139855952.233
(2006) · Elsevier eBooks · doi:10.1016/b0-44-451005-2/00513-1
ADVERSE CARDIOVASCULAR EFFECTS OF NON-CARDIOVASCULAR DRUGS
(2009) · Elsevier eBooks · doi:10.1016/b978-0-444-53268-8.50009-0
(2015) · Elsevier eBooks · doi:10.1016/b978-0-444-53717-1.00753-8
(2015) · Elsevier eBooks · doi:10.1016/b978-0-444-53717-1.00933-1
Chiou, C. C., Groll, A. H., & Walsh, T. J. (2000) · Side effects of drugs annual · doi:10.1016/s0378-6080(00)80033-1
Alby‐Laurent, F., Chahla, W. A., Brethon, B., Dupont, D., Gandemer, V., Gueguen, G., Lanternier, F., Pasquet, M., Philippe, M., Pluchart, C., et al. (2022) · Bulletin du Cancer · doi:10.1016/j.bulcan.2022.08.004
Medical and Surgical Management of Phaeohyphomycosis in a Kea (Nestor notabilis)
Kirk, N., Antinoff, N., & Echols, M. S. (2022) · Journal of Avian Medicine and Surgery · doi:10.1647/21-00048
Azole-based organometallic compounds as bioactive agents
Krishna, Yadav, D., Kumar, S., Meenakshi, M., Kumar, A., & Kumar, V. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-90596-1.00009-2
Effectiveness of drug repurposing approach against Candida isolates
Ansari, A., Saini, M. K., Kumar, D., Rai, N., & Kumar, N. (2024) · Environment Conservation Journal · doi:10.36953/ecj.30540224
Groll, A. H., & Walsh, T. J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-82763-8.00256-9
Etude fonctionnelle et inhibition de la protéine Bdf1 chez Candida albicans
Champleboux, M. (2016) · theses.fr (ABES) · doi:10.70675/07079ce8z25e3z45dfz98e6ze8e3ccbc6182
Developing a novel antifungal strategy by targeting an epigenetic reader domain
Wei, K. (2020) · theses.fr (ABES) · doi:10.70675/ce7dc30ezfb21z43adz8835zf9a2e73daf67
Norman, H. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44037-3.00193-7
Sharma, V., Kaur, N., & Sharma, R. K. (2026) · Scripta Medica · doi:10.5937/scriptamed57-61321
Metadata
- Authors
- Groll, A. H., Piscitelli, S. C., & Walsh, T. J.
- Affiliations
- National Institutes of Health (US)
- Venue
- Advances in pharmacology
- Publisher
- Elsevier
- Published
- 1998
- Volume
- 44
- Pages
- 343-500
- ISSN
- 1054-3589 (ISSN-L)
- OpenAlex
- W63281979
- Cited by
- 377
- References
- 930
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 16 · 2023: 7 · 2022: 12 · 2021: 8 · 2020: 13 · 2019: 7 · 2018: 8 · 2017: 10 · 2016: 13 · 2015: 13 · 2014: 16 · 2013: 13 · 2012: 7
- FWCI
- 54.29
- Type
- book chapter
- Language
- en
- Open access
- closed
- Locations
- Advances in pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Keywords
- systemic antifungal agents, clinical pharmacology, antifungal drug development, antifungal drug targets, fungal infection
- MeSH terms
- Animals, Antifungal Agents, Fungi, Humans, Mycoses, Triazoles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
